|
Volumn 21, Issue 5, 2014, Pages 869-870
|
Regadenoson and seizures: A real clinical concern
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE A2A RECEPTOR;
AMINOPHYLLINE;
GLUTAMINE;
REGADENOSON;
ATROPINE;
PURINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
COMPUTER ASSISTED TOMOGRAPHY;
CONVULSION;
DISEASE ASSOCIATION;
DRUG APPROVAL;
DRUG INDUCED DISEASE;
DRUG LABELING;
DRUG PACKAGING;
DRUG SAFETY;
EDITORIAL;
EPILEPTOGENESIS;
EXCITOTOXICITY;
FOOD AND DRUG ADMINISTRATION;
HEART BLOCK;
HUMAN;
INTENSIVE CARE;
MEDICAL HISTORY;
MENTAL DISEASE;
NONHUMAN;
ORGANIC BRAIN SYNDROME;
PATIENT MONITORING;
POSTMARKETING SURVEILLANCE;
RECURRENT DISEASE;
REFERENCE DATABASE;
SEIZURE;
SEIZURE SUSCEPTIBILITY;
ADVERSE EFFECTS;
ANTAGONISTS AND INHIBITORS;
BRADYCARDIA;
CHEMICALLY INDUCED;
EXERCISE TEST;
HYPOTENSION;
ATROPINE;
BRADYCARDIA;
EXERCISE TEST;
HUMANS;
HYPOTENSION;
PURINES;
PYRAZOLES;
|
EID: 84919791748
PISSN: 10713581
EISSN: 15326551
Source Type: Journal
DOI: 10.1007/s12350-014-9970-9 Document Type: Editorial |
Times cited : (13)
|
References (5)
|